The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...